A comprehensive perspective of Huntington's disease and mitochondrial dysfunction.

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
• It is characterized by CAG trinucleotide repeat expansion in the HTT gene.
• HD presents with motor, cognitive, and psychiatric symptoms, ultimately impairing vital functions.

Purpose of the Study:

• To review and discuss the role of mitochondrial dysfunction in Huntington's disease pathogenesis.
• To explore the specific mechanisms of mitochondrial dysregulation in HD.
• To provide a comprehensive perspective on the link between mitochondrial health and HD progression.

Main Methods:

• Literature review of recent research advances on mitochondrial dysfunction in HD.
• Analysis of studies focusing on bioenergetics, autophagy, and mitochondrial membranes in HD.
• Synthesis of findings to elucidate the relationship between mitochondrial dysregulation and HD.

Main Results:

• Mitochondrial dysfunctions are implicated as a key factor in HD pathogenesis.
• Specific areas of dysfunction include impaired bioenergetics, abnormal autophagy, and altered mitochondrial membranes.
• These dysfunctions contribute to the neurodegenerative processes observed in HD.

Conclusions:

• Mitochondrial dysregulation plays a critical role in the development and progression of Huntington's disease.
• Understanding these mechanisms offers potential therapeutic targets for HD.
• Further research into mitochondrial pathways is crucial for developing effective HD treatments.